StockMarketWire.com - Numis today reaffirms its buy investment rating on Spire Healthcare Group [LON:SPI] and cut its price target to 163p (from 280p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk